Introduction

Adverse Drug Reaction (ADR) Monitoring in hospitals is a systematic, continuous process of detecting, assessing, understanding, and preventing adverse effects or any other drug-related problems in patients. It forms a core component of pharmacovigilance, ensuring patient safety and rational use of medicines within healthcare settings.

An ADR is defined as any noxious, unintended, and harmful response to a drug occurring at normal therapeutic doses. In hospital environments—especially in intensive care units, oncology wards, and polypharmacy cases—the risk of ADRs is significantly higher due to complex treatment regimens and vulnerable patient populations.

ADR monitoring bridges clinical pharmacy, therapeutics, and regulatory science by enabling early detection of drug-related harm, improving therapeutic outcomes, and supporting evidence-based prescribing practices. It aligns with national and global pharmacovigilance frameworks such as the Pharmacovigilance Programme of India (PvPI) and international guidelines.

The scope of ADR Monitoring in hospitals is extensive and multidisciplinary, encompassing:

• Detection and Reporting of ADRs: Identification of suspected ADRs and systematic reporting through hospital pharmacovigilance systems and national programs.
• Causality, Severity, and Preventability Assessment: Use of standardized tools (e.g., WHO-UMC scale, Naranjo algorithm) to evaluate the relationship between drug and reaction.
• Risk Management and Prevention: Implementation of strategies to minimize ADR occurrence, including dose adjustment, monitoring plans, and alternative therapies.
• Pharmacovigilance Integration: Contribution to national databases like PvPI and global safety monitoring systems.
• Clinical Decision Support: Assisting clinicians in modifying therapy based on ADR findings.
• Special Population Monitoring: Enhanced surveillance in pediatric, geriatric, pregnant, and critically ill patients.
• Education and Awareness: Training healthcare professionals on ADR identification and reporting practices.
• Regulatory Compliance: Ensuring adherence to CDSCO guidelines and hospital accreditation standards (e.g., NABH).

The primary objectives of ADR Monitoring in Hospitals include:

1. To Ensure Patient Safety
   Detect and minimize harmful drug reactions in clinical practice.
2. To Improve Therapeutic Outcomes
   Optimize drug therapy by balancing efficacy and safety.
3. To Promote Rational Drug Use
   Encourage evidence-based prescribing and reduce irrational polypharmacy.
4. To Detect Unknown or Rare ADRs
   Identify new, serious, or unexpected adverse reactions.
5. To Support Pharmacovigilance Systems
   Contribute data to national and international drug safety databases.
6. To Reduce Healthcare Costs
   Prevent ADR-related hospitalizations and prolonged treatment.
7. To Enhance Clinical Decision-Making
   Provide actionable insights for therapy modification and patient management.

This module on ADR Monitoring in Hospitals is suitable for:

• Final-year B.Pharm students preparing for GPAT and other competitive examinations
• Pharmacy graduates interested in clinical pharmacy and pharmacovigilance careers
• M.Pharm aspirants specializing in pharmacology, pharmacy practice, or pharmacovigilance
• Clinical and hospital pharmacists involved in patient safety and drug monitoring
• Medical and healthcare professionals engaged in prescribing and patient care
• Pharmacovigilance professionals working with ADR reporting systems and safety databases
• Clinical research associates and regulatory professionals involved in drug safety evaluation